84-1146-64 CAPN9, NT (Calpain-9, Digestive Tract-specific Calpain, New Calpain 4, nCL-4, Protein CG36, NCL4) 200ul C1035-29Y1
特徴
- CAPN9 has been implicated in neurodegenerative processes, as their activation can be triggered by calcium influx and oxidative stress.
- The protein is expressed predominantly in stomach and small intestine and may have specialized functions in the digestive tract.
- This protein is thought to be associated with gastric cancer.
- Applications:Suitable for use in ELISA and Western Blot.
- Other applications not tested.
- Recommended Dilution:ELISA: 1:1,000Western Blot: 1:50-1:100Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for at least 12 months.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size：200ul
- Host：rabbit
- Source Antibody：human
- Grade：Purified
- Purity：Purified by ammonium sulfate precipitation.
- Form：Supplied as a liquid in PBS, 0.09% sodium azide.
- Specificity：Recognizes human CAPN9.
- Isotype：IgG
- Calc Applications Abbrev：E WB
- Calc Crossreactivity：Hu
- Immunogen：Synthetic peptide selected from the N-terminal region of human CAPN9 (KLH).
- Shelf Life：1year
- EU Commodity Code：30021010
- この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL：06-6447-8641
- FAX：06-6447-8642
- E-mail：[email protected]
